GPT Healthcare Board of Directors
Get the latest insights into the leadership at GPT Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Ankur Sharma | Company Secretary & Compliance Officer |
| Om Tantia | Chairman & Managing Director |
| Aruna Tantia | Non Independent & Non Executive Director |
| Anurag Tantia | Executive Director |
| Ghanshyam Goyal | Non Independent & Non Executive Director |
| Deepak Pramanik | Non Executive Independent Director |
| Kashi Prasad Khandelwal | Non Executive Independent Director |
| Amrendra Prasad Verma | Non Executive Independent Director |
| Hari Modi | Non Executive Independent Director |
| Tapti Sen | Non Executive Independent Director |
| Shree Gopal Tantia | Vice Chairman |
GPT Healthcare FAQs
The board at GPT Healthcare consists of experienced professionals, including Ankur Sharma, Om Tantia, and others, overseeing the company’s strategic and corporate governance.
Directors at GPT Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Ankur Sharma is the current chairman at GPT Healthcare.
Executive directors at GPT Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, GPT Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At GPT Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
